| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |